WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'3801 Infant (under 12 months) mortality rate: 692
GDP / capita (US$): 4'6991 Child (under 5 years) mortality rate: 862

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 182'143  179'160  176'166  173'149  170'094  143'832  111'091  79'984 
Births 4'599  4'604  4'609  4'611  4'601  4'461  4'469  3'406 
Surviving infants 4'303  4'301  4'300  4'296  4'281  4'107  4'057  3'045 
Pop. less than 5 years 21'761  21'996  21'897  21'312  20'970  21'051  19'305  13'779 
Pop. less than 15 years 61'610  61'730  61'699  61'361  61'239  59'626  48'433  34'596 
Female 15-49 years 47'294  46'198  45'135  44'161  43'055  32'901  24'172  17'216 

Number of reported case

(Click for retrospective incidence data for Pakistan)
Diphtheria 183  98  22  37  34  13  1'371  14'328 
Japanese encephalitis
Measles 8'749  8'046  4'386  4'321  863  2'064  21'785  28'573 
Mumps
Pertussis 250  60  156  109  164  160  24'545  42'947 
Polio* 138  74  198  144  89  199  777  2'980 
Rubella 1'113  483  189 
Rubella (CRS)
Tetanus (neonatal) 898  320  505  508  781  1'380  1'067  1'085 
Tetanus (total) 898  320  516  559  816  1'465  4'080  2'738 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Pakistan)
Vaccine year result method % card seen                                                
BCG 2012  85  DHS   36  80  95  95  95  90  94  93 
DTP1 2012  79  DHS   36  75  94  94  90  90  88 
DTP3 2012  65  DHS   36  66  89  89  88  85  78  83 
HepB_BD         
HepB3 2012  65  DHS   36  66  89  89  88  85 
Hib3 2012  65  DHS   36  66  89  89  88  85 
JapEnc         
MCV 2012  61  DHS   36  61  88  88  86  80  75  76 
MCV2          58  53  53  51  30 
PCV1          65 
PCV3          65 
Pol3 2012  85  DHS   36  66  89  89  88  85  74  83 
Rota1         
Rota_last         
Rubella1         
TT2plus 2001  38       62  68  68  74  55  51  40 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Pakistan)
BCG 85  85  84  90  81  74  80 
DTP1 79  79  84  88  88  72  77  20 
DTP3 72  72  74  82  71  62  54 
HepB3 72  72  78  82  78 
HepB_BD
Hib3 72  72  75  86  76 
MCV 61  61  63  69  57  59  50 
MCV2 58  53  53  51  30 
PAB 75  75  75  84  84  71  50 
PCV3 66 
Pol3 72  72  75  82  70  65  54 
Rota_last

Number of districts in the country 147  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 61
From 80 to 89% 13
From 50 to 79% 16
Less than 50% 10
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9, 15 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; No
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-15  2011-2015  2011 - 2015  2011-2015  2009-2014  2009-2014  2004-05 to 2008-09 
Nº of districts with microplans that include activities to raise immunization coverage number 147    120  78  135  135  60 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 147  146  142  139  135  135  133 
Nº districts with DTP3 coverage >=80% number 109  108  109  100  83  50  23 
% of districts with DTP3 coverage >=80% From 0 to 100% 74  74  77  72  61  37  17 
Nº districts with measles (MCV1) coverage >=95% number 86  86  64  62  44  34   
% of districts with MCV1 coverage >=95% From 0 to 100% 59  59  45  45  33  25   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  Yes    Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 11      100  80  100  31 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.